SL Pharma Labs has expanded its CRO services to include quality control analytical and microbiological support for marketed pharmaceutical products including parenterals and topicals. The move was driven by client demand.

In April 2012, SL successfully completed a comprehensive GMP compliance inspection in support of a client’s marketed parenteral products.

“Global pharmaceutical companies are looking for CRO partners that can provide focused expertise in drug product support along with the ability to be responsive and flexible,” says Dr. Waheed Sheikh, founder and president of SL Pharma Labs. “SL Pharma Labs’ business model is consistent with the new challenges faced by today’s developers and marketers of pharmaceutical products.”

In addition to working directly with pharmaceutical companies, SL Pharma Labs collaborates with CMO organizations and other service providers where critical functions in the drug development and commercialization process are outsourced.